JonesTrading analyst Soumit Roy reiterated a Buy rating on Anavex Life Sciences (AVXL - Research Report) today and set a price target of $40.00. The company's shares closed yesterday at $10.80.According to TipRanks, Roy is a 4-star analyst with an average return of 4.5% and a 31.70% success rate. Roy covers the Healthcare sector, focusing on stocks such as Mirati Therapeutics, Anavex Life Sciences, and Aileron Therapeutics.Anavex Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $35.20, which is a 225.93% upside from current levels. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $42.
https://www.tipranks.com/news/blurbs/anavex-life-sciences-avxl-gets-a-buy-from-jonestrading?utm_source=advfn.com&utm_medium=referral
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Aug 2022 to Sep 2022 Click Here for more Anavex Life Sciences Charts.
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Sep 2021 to Sep 2022 Click Here for more Anavex Life Sciences Charts.